Weikang Pharmaceutical announced that its wholly-owned subsidiary Weikang Commercial signed a letter of intent to acquire shares with Zhejiang Kangbaijia to sell 100% of its shares in Weikang Retail and Weikang Pharmacy. Zhejiang Kangbaijia will be purchasing with cash payment. The deal is still in the planning stage, and the specific plan is yet to be negotiated. The registered capital of Weikang retail is 60 million yuan, and the registered capital of Weikang Pharmacy is 30 million yuan. The main financial indicators are subject to audit and evaluation. Once the transaction is completed, it will result in a change in the scope of the consolidated statement, but there will be no significant impact.